Thank you, Mr. Chair.
Ms. Combs, in response to a question from Mr. Aboultaif, you stated that at the worst moment of the crisis, you had adopted a policy of providing vaccines on a not‑for‑profit basis because you had received public funds to develop the vaccine. We know that Pfizer, for example, said that it never received any public money to develop its vaccine and that it made a profit of $37 billion U.S. in 2021 alone.
Why did you choose to move from a not‑for‑profit vision to one where it was possible to make a profit too?